TABLE 1.
Characteristics of the study population
| LVH (N = 160) | non‐LVH (N = 160) | P value | |
|---|---|---|---|
| Demographic characteristic | |||
| Age | 54.14 ± 3.35 | 54.21 ± 3.86 | .891 |
| BMI (kg/m2) | 23.55 ± 2.50 | 23.65 ± 2.60 | .790 |
| WHR | 0.83 ± 0.06 | 0.83 ± 0.66 | .712 |
| Smoking, n (%) | 2 (1%) | 0 (0%) | .316 |
| Alcohol drinking, n (%) | 28 (18%) | 23 (14%) | .329 |
| The course of hypertension | 5.02 ± 2.48 | 5.34 ± 2.53 | .368 |
| Menopausal interval | |||
| ≥5 years, n (%) | 110 (69%) | 93 (58%) | .106 |
| <5 years, n (%) | 50 (31%) | 67 (42%) | |
| Educational level | |||
| ≥college degree, n (%) | 85 (53%) | 100 (63%) | .152 |
| <college degree, n (%) | 75 (47%) | 60 (38%) | |
| Family history of hypertension, n (%) | 58 (36%) | 35 (22%) | .029 |
| Current antihypertensive drugs | |||
| ACEI, n (%) | 21 (13%) | 38 (24%) | .045 |
| ARB, n (%) | 61 (38%) | 85 (53%) | .033 |
| Beta‐blockers, n (%) | 10 (6%) | 16 (10%) | .297 |
| CCB, n (%) | 107 (67%) | 110 (69%) | .762 |
| Diuretic, n (%) | 43 (27%) | 35 (22%) | .411 |
Abbreviations: ACEI, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; BMI, body mass index; CCB, calcium channel blocker; DIU, diuretic; LVH, left ventricular hypertrophy; WHR, waist‐hip ratio.